Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#81 / 147 Total
SERA - Sera Prognostics Inc - Stock Price Chart
TickerSERA [NASD]
CompanySera Prognostics Inc
CountryUSA
IndustryDiagnostics & Research
Market Cap311.79MEPS (ttm)-1.07
P/E-EPS this Y14.66%
Forward P/E-EPS next Y4.04%
PEG-EPS past 5Y-21.21%
P/S1484.72EPS next 5Y-
P/B4.81EPS Q/Q26.22%
Dividend-Sales Q/Q-100.00%
Insider Own43.40%Inst Own39.46%
Insider Trans-2.06%Inst Trans0.26%
Short Float1.37%EarningsMay 08/a
Analyst Recom1.67Target Price2.75
Avg Volume176.11K52W Range1.52 - 12.35
Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kearney PaulChief Data OfficerMay 15 '24Sale8.2410,38785,589185,300May 15 06:23 PM
Lindgardt ZhenyaChief Executive OfficerMay 08 '24Sale9.5911,992115,003896,112May 10 05:41 PM
Aerts AustinChief Financial OfficerMay 08 '24Sale9.596,59263,217315,896May 10 05:41 PM
Harrison Robert GardnerChief Information OfficerMay 08 '24Sale9.594,90247,010140,795May 10 05:40 PM
Boniface John J.Chief Scientific OfficerMay 08 '24Sale9.594,90247,010134,869May 10 05:41 PM
BWAQ - Blue World Acquisition Corp - Stock Price Chart
TickerBWAQ [NASD]
CompanyBlue World Acquisition Corp
CountryUSA
IndustryShell Companies
Market Cap51.24MEPS (ttm)0.18
P/E50.77EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.66EPS Q/Q-56.37%
Dividend-Sales Q/Q-
Insider Own34.25%Inst Own55.33%
Insider Trans0.00%Inst Trans1.30%
Short Float0.06%Earnings-
Analyst Recom-Target Price-
Avg Volume38.21K52W Range7.44 - 15.61
May-16-24 08:35AM Blue World Acquisition Corporation Announces the Redemption Deadline as May 23, 2024 for the Extraordinary General Meeting to Approve the Business Combination with TOYO Solar (GlobeNewswire)
May-03-24 06:10AM Blue World Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination (GlobeNewswire)
Apr-15-24 08:07AM Blue World Acquisition Corporation Postponed the Extraordinary General Meeting to Approve the Business Combination with TOYO Solar Pending A Post-Effective Amendment to The Registration Statement (GlobeNewswire)
Apr-03-24 07:00AM Blue World Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination (GlobeNewswire)
Mar-01-24 08:00AM Blue World Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination (GlobeNewswire)
Feb-06-24 04:00PM Blue World Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination (GlobeNewswire)
Jan-29-24 04:00PM Blue World Acquisition Corporation Announces Liquidation of Investments Held in the Trust Account into Cash (GlobeNewswire)
Jan-02-24 04:00PM Blue World Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination (GlobeNewswire)
Dec-04-23 04:00PM Blue World Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination (GlobeNewswire)
Nov-01-23 04:00PM Blue World Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination (GlobeNewswire)
Blue World Acquisition Corp. operates as a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The company was founded on July 19, 2021 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Blue World Holdings Ltd10% OwnerOct 20 '23Sale3.00400,0001,200,0001,880,000Oct 24 04:41 PM
FRSX - Foresight Autonomous Holdings Ltd ADR - Stock Price Chart
TickerFRSX [NASD]
CompanyForesight Autonomous Holdings Ltd ADR
CountryIsrael
IndustryAuto Parts
Market Cap17.63MEPS (ttm)-1.35
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y14.49%
P/S32.65EPS next 5Y-
P/B1.26EPS Q/Q76.48%
Dividend-Sales Q/Q83.64%
Insider Own-Inst Own6.58%
Insider Trans-Inst Trans-
Short Float3.29%EarningsMay 28/b
Analyst Recom1.00Target Price4.62
Avg Volume444.51K52W Range0.90 - 3.29
Foresight Autonomous Holdings Ltd. is engaged in the research and development of vehicular accident prevention products. Its product is QuadSight, a multi-spectral vision solution for detection of obstacles in harsh lightining and weather conditions. The company was founded by Haim Siboni on September 19, 1977 and is headquartered in Ness Ziona, Israel.
INDP - Indaptus Therapeutics Inc - Stock Price Chart
TickerINDP [NASD]
CompanyIndaptus Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap23.57MEPS (ttm)-1.78
P/E-EPS this Y-4.64%
Forward P/E-EPS next Y27.15%
PEG-EPS past 5Y56.03%
P/S-EPS next 5Y-
P/B2.52EPS Q/Q10.94%
Dividend-Sales Q/Q-
Insider Own30.86%Inst Own6.88%
Insider Trans0.00%Inst Trans12.55%
Short Float0.28%EarningsMay 08/b
Analyst Recom1.00Target Price10.00
Avg Volume88.73K52W Range1.56 - 4.08
Today 08:00AM Indaptus Therapeutics to Present New Cohort Data Confirming Original Pulse-Prime Hypothesis Via Phase 1 Clinical Trial of Decoy20 at the American Society of Clinical Oncology Annual Meeting (GlobeNewswire) +12.20%
May-22-24 08:00AM Indaptus Therapeutics Announces Completion of First Patient to Receive Multiple Doses of Decoy20, the Company's Broad-Based, Pulse-Prime Immuno-Oncology Therapy for Advanced Solid Tumors (GlobeNewswire) +5.53%
May-08-24 12:54PM INDP Stock Earnings: Indaptus Therapeutics Misses EPS for Q1 2024 (InvestorPlace)
08:00AM Indaptus Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Apr-11-24 07:30AM Indaptus Therapeutics Presents Positive Mechanism of Action Data at the American Association for Cancer Research Annual Meeting (GlobeNewswire) +9.13%
Mar-28-24 08:00AM Indaptus Therapeutics to Present at the MedInvest Biotech and Pharma Investor Conference (GlobeNewswire) -10.04%
Mar-25-24 08:30AM Indaptus Therapeutics Previews Positive Mechanism of Action Data to be Presented at the American Association for Cancer Research Annual Meeting (GlobeNewswire) +6.90%
Mar-18-24 08:00AM Indaptus Therapeutics to Participate in Tribe Public Webinar On Wednesday, March 20, 2024 (GlobeNewswire)
Mar-13-24 07:30AM Indaptus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-04-24 07:30AM Indaptus Therapeutics Announces Positive Results from Second Cohort of Phase 1 Trial; Company Initiates Multi-Dose Cohort (GlobeNewswire) +12.92%
Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company. It engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. The firm created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Anderson Glen R.10% OwnerAug 14 '23Buy2.3423,93456,0061,190,400Aug 16 06:01 PM
Anderson Glen R.10% OwnerAug 11 '23Buy2.1235,06474,3361,166,466Aug 16 06:01 PM
Anderson Glen R.10% OwnerAug 10 '23Buy1.9444,35486,0471,131,402Aug 16 06:01 PM
GSIW - Garden Stage Ltd - Stock Price Chart
TickerGSIW [NASD]
CompanyGarden Stage Ltd
CountryHong Kong
IndustryCapital Markets
Market Cap112.62MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B441.69EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own0.30%
Insider Trans-Inst Trans-
Short Float0.51%Earnings-
Analyst Recom-Target Price-
Avg Volume22.21K52W Range4.20 - 15.99
Garden Stage Ltd. is a holding company, which engages in the provision of placing and underwriting services. It also offers securities dealing and brokerage, and asset management services. The company was founded on August 11, 2022 and is headquartered in Hong Kong.
BCTX - BriaCell Therapeutics Corp - Stock Price Chart
TickerBCTX [NASD]
CompanyBriaCell Therapeutics Corp
CountryCanada
IndustryBiotechnology
Market Cap28.15MEPS (ttm)-1.67
P/E-EPS this Y-6.92%
Forward P/E-EPS next Y28.06%
PEG-EPS past 5Y32.71%
P/S-EPS next 5Y-
P/B-EPS Q/Q7.71%
Dividend-Sales Q/Q-
Insider Own17.68%Inst Own12.04%
Insider Trans38.77%Inst Trans-
Short Float4.44%EarningsMar 19/b
Analyst Recom1.00Target Price18.00
Avg Volume120.47K52W Range1.27 - 7.59
BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company, which engages in the development of immunotherapies for the treatment of cancer. Its technologies include Bria-IMT and Bria-OTS. The company was founded by Charles L. Wiseman and Isaac B. Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lustig MarcDirectorMay 14 '24Buy2.21902,9352,000,0012,542,935May 20 04:00 PM
AEZS - Aeterna Zentaris Inc. - Stock Price Chart
TickerAEZS [NASD]
CompanyAeterna Zentaris Inc.
CountryCanada
IndustryBiotechnology
Market Cap12.40MEPS (ttm)-29.08
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S5.23EPS next 5Y-
P/B0.24EPS Q/Q-440.73%
Dividend-Sales Q/Q-99.81%
Insider Own0.14%Inst Own1.08%
Insider Trans0.00%Inst Trans-
Short Float0.34%EarningsMay 16/b
Analyst Recom1.00Target Price60.00
Avg Volume6.38K52W Range5.44 - 12.80
Aeterna Zentaris, Inc. is a specialty biopharmaceutical company, which engages in the development and commercialization of therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.
VCSA - Vacasa Inc - Stock Price Chart
TickerVCSA [NASD]
CompanyVacasa Inc
CountryUSA
IndustrySoftware - Application
Market Cap58.67MEPS (ttm)-28.42
P/E-EPS this Y63.25%
Forward P/E-EPS next Y78.23%
PEG-EPS past 5Y-
P/S0.05EPS next 5Y-2.96%
P/B3.38EPS Q/Q-216.85%
Dividend-Sales Q/Q-18.45%
Insider Own49.64%Inst Own36.27%
Insider Trans-7.83%Inst Trans190.20%
Short Float7.41%EarningsMay 09/a
Analyst Recom2.75Target Price7.25
Avg Volume102.32K52W Range3.82 - 16.80
Vacasa, Inc. engages in the provision of a vertically integrated vacation rental management platform. The firm is also involved in supplying the short-term rental market and in a growing homeowner base. The company was founded on July 1, 2021 and is headquartered in Portland, OR.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mossytree Inc.10% OwnerFeb 16 '24Sale9.1912,500114,935287,505Feb 20 10:41 AM
Mossytree Inc.10% OwnerFeb 15 '24Sale8.52412,5003,515,800300,005Feb 20 10:41 AM
Mossytree Inc.10% OwnerFeb 14 '24Sale9.2412,500115,451712,505Feb 14 08:02 PM
Mossytree Inc.10% OwnerFeb 13 '24Sale9.0811,507104,507725,005Feb 14 08:02 PM
Mossytree Inc.10% OwnerFeb 12 '24Option Exercise0.00550,0000736,512Feb 14 08:02 PM
PDYN - Palladyne AI Corp. - Stock Price Chart
TickerPDYN [NASD]
CompanyPalladyne AI Corp.
CountryUSA
IndustrySoftware - Infrastructure
Market Cap54.53MEPS (ttm)-3.94
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S7.48EPS next 5Y-
P/B1.59EPS Q/Q-98.79%
Dividend-Sales Q/Q49.87%
Insider Own46.49%Inst Own6.94%
Insider Trans1.69%Inst Trans185.68%
Short Float3.33%EarningsNov 14/a
Analyst Recom3.00Target Price1.00
Avg Volume573.92K52W Range0.40 - 3.25
May-13-24 08:52AM PDYN Stock Earnings: Palladyne AI Misses Revenue for Q1 2024 (InvestorPlace)
Apr-16-24 07:52AM PDYN Stock Earnings: Palladyne AI Misses EPS, Misses Revenue for Q2 2023 (InvestorPlace) -8.47%
Apr-08-24 09:00AM Palladyne AI Ticker Symbol now PDYN (Business Wire) +6.91%
Palladyne AI Corp. engages in the design, development, and manufacture of industrial robotic systems that augment human performance by combining human intelligence, instinct, and judgment with the strength, endurance, and precision of machines to enhance employee safety and productivity. Its mobile robotic systems include the Guardian S, Guardian GT, Guardian XO, and Guardian XT. The company was founded in 2015 and is headquartered in Salt Lake City, UT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WEIBLING DENNIS MDirectorMay 28 '24Buy1.8423,97644,022150,000May 29 04:38 PM
WEIBLING DENNIS MDirectorMay 24 '24Buy1.9915,92631,723126,024May 28 05:29 PM
Wolff Benjamin GPRESIDENT & CEOMay 22 '24Buy1.968,00015,6801,287,946May 23 04:30 PM
WEIBLING DENNIS MDirectorMay 22 '24Buy1.957,20814,078110,098May 23 04:32 PM
WEIBLING DENNIS MDirectorMay 21 '24Buy1.802,8905,202102,890May 22 04:46 PM
SGHT - Sight Sciences Inc - Stock Price Chart
TickerSGHT [NASD, RUT]
CompanySight Sciences Inc
CountryUSA
IndustryMedical Devices
Market Cap314.48MEPS (ttm)-1.12
P/E-EPS this Y9.12%
Forward P/E-EPS next Y20.28%
PEG-EPS past 5Y-30.17%
P/S3.86EPS next 5Y-
P/B2.87EPS Q/Q6.78%
Dividend-Sales Q/Q2.34%
Insider Own45.05%Inst Own32.07%
Insider Trans-11.05%Inst Trans-3.38%
Short Float4.54%EarningsMay 02/a
Analyst Recom2.67Target Price6.10
Avg Volume155.19K52W Range1.04 - 9.73
Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2011 and is headquartered in Menlo Park, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bauerlein AlisonChief Financial OfficerMay 17 '24Sale5.4213,06670,870413,182May 20 08:56 PM
Badawi PaulPresident and CEOApr 03 '24Sale5.0812,57163,8485,750,729Apr 04 07:25 PM
Bauerlein AlisonChief Financial OfficerApr 03 '24Sale5.0810,12351,415426,248Apr 04 07:19 PM
HAYDEN JEREMY B.Chief Legal OfficerApr 03 '24Sale5.084,89324,852168,620Apr 04 07:26 PM
Park Sam BoongChief Operating OfficerApr 03 '24Sale5.083,41417,340261,754Apr 04 07:24 PM
1456789101112131415